When it comes to the biotech stocks that experienced strong growth in 2020, the author of today’s article notes that the “more obvious cases such as vaccine company Moderna have […]
read more
The Co-Managers Of An Outperforming Fund Share 3 Biotech Firms Poised To Solve Future Disease Outbreaks
The Shelton Green Alpha Fund is up more than 100% year-to-date and is among the best-performing funds of 2020 – and a big reason for its outperformance is its biotech […]
read more
Blocking Cancer’s “Cloaking Signal” Creates A Massive Opportunity For This Biotech
With two innovative cancer treatment candidates that seek to block the “cloaking signal” used by cancer cells to trick the immune system into not attacking them, the small biotech highlighted […]
read more
New Stocks To Watch In Biotech, Cleantech, Psychedelics & More
Today’s article highlights a plethora of new stocks to watch in the biotech, tech, cleantech, psychedelics and cannabis spaces, among others. In regards to the biotech names, the author notes […]
read more
What Makes This Biotech An Attractive Investment Opportunity? An Impressive Brain Trust, A Supercomputer, The Third-Largest Biotech IPO In History – And More
Why might investors looking to get in on the next big biotech trend want to consider picking up shares of the company highlighted in today’s article? As the author explains, […]
read more
An Overlooked Biotech With A Revolutionary Diabetes Drug Creates An Attractive Buying Opportunity
Since the discovery of insulin almost 100 years ago, there has been no novel therapy introduced for Type 1 diabetes. That could change in the coming months, however, if the […]
read more
Its Diabetes-Delaying Drug Could Be A Game-Changer For This Under-The-Radar Biotech
What makes the clinical-stage biotech highlighted in today’s article, one focused on developing drugs to prevent certain diseases, worth strongly considering? Its most exciting drug candidate seeks to delay the […]
read more
Better Pick A COVID-19 Vaccine Play
When it comes to which of the two biotech stocks with COVID-19 vaccine candidates focused on in today’s article is the better pick going forward, especially for aggressive investors, the […]
read moreRemdesivir’s COVID-19 Success Could Create A Big “Piggyback” Opportunity For This Under-The-Radar Biotech
There is currently only one drug that has demonstrated the potential to be a safe and effective treatment for COVID-19 in clinical trials: Gilead Sciences’ remdesivir. Today’s article, however, highlights […]
read moreThese Biotechs Are Surging Along With Coronavirus Infections
As the number of cases of infection by the novel coronavirus around the world rises, so are shares of a number of biotech companies with exposure to experimental vaccines (as […]
read more